跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
RIFADIN rifampicin 20mg/mL oral liquid bottle
Approved
STANDARD
RIFADIN rifampicin 20mg/mL oral liquid bottle
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a1c54a6a45d56ee7
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
a1c54a6a45d56ee7
Product Name
RIFADIN rifampicin 20mg/mL oral liquid bottle
Artg Id
10113
Artg Name
RIFADIN rifampicin 20mg/mL oral liquid bottle
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
1991-07-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/154dc6dcd61a7976ad3d9183f03d5d74.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/98ca4d3ab15bef304839254546b5aa37.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a1c54a6a45d56ee7
Type
Standard
Back to TGA Approvals
RIFADIN rifampicin 20mg/mL oral liquid bottle - TGA Drug Approval Details